It is believed that adropin can play a significant role in maintaining metabolic homeostasis, increasing the glucose utilization at the expense of fatty acids, improving glucose tolerance, and reducing insulin resistance [40,41,42]. The gene discussed is ENHO; the disease is Insulin resistance.